← All organizations
Highest phase reached
Phase 2
First clinical trial
Oct 1, 2013Last known activity
Mar 1, 2016
Acquired by Allergan PLC (2015) → AbbVie on Aug 11, 2016
Timeline
2010s
- Jan 1, 2010
ForSight Vision 5— Founded
- Aug 11, 2016
Allergan PLC (2015)— Acquired By
- Jun 26, 2019
AbbVie— Now
Drugs by trial phase (2 distinct, 7 trials)
Phase 2 (2 own, 0 via acquisition)
Indications
Recent trials (12)
- NCT02742649Lead sponsorPhase 1/Phase 2Mar 1, 2016
- NCT02742649Study directorPhase 1/Phase 2Mar 1, 2016
- NCT02537015Lead sponsorPhase 1/Phase 2Aug 1, 2015
- NCT02537015Study directorPhase 1/Phase 2Aug 1, 2015
- NCT02444767Study directorPhase 1Mar 1, 2015
- NCT02444767Lead sponsorPhase 1Mar 1, 2015
- NCT02358369Lead sponsorPhase 2Jan 1, 2015
- NCT02358369Study directorPhase 2Jan 1, 2015
- NCT02143843Lead sponsorPhase 1/Phase 2May 1, 2014
- NCT01943721Lead sponsorPhase 1Oct 1, 2013
- NCT01915940Lead sponsorPhase 2Oct 1, 2013
- NCT01943721Study directorPhase 1Oct 1, 2013
Details
- Founded
- Menlo Park, CA, US Jan 1, 2010
- Last known activity
- Mar 1, 2016